Skip to content
10-Q

Quarterly Report

agilon health, inc. AGL

0001628280-25-022691

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 413.95M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $0
Long Term Debt Q1 2025 · Dec 31, 2024 $34.9M
Short Term Debt Q1 2025 · Mar 31, 2025 $34.92M
Short Term Debt Q1 2025 · Dec 31, 2024 $0
Cash And Equivalents Q1 2025 · Mar 31, 2025 $136.94M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $188.23M
Current Liabilities Q1 2025 · Mar 31, 2025 $1.37B
Current Liabilities Q1 2025 · Dec 31, 2024 $1.15B
Total Liabilities Q1 2025 · Mar 31, 2025 $1.43B
Total Liabilities Q1 2025 · Dec 31, 2024 $1.26B
Current Assets Q1 2025 · Mar 31, 2025 $1.65B
Current Assets Q1 2025 · Dec 31, 2024 $1.46B
Total Assets Q1 2025 · Mar 31, 2025 $1.93B
Total Assets Q1 2025 · Dec 31, 2024 $1.73B
Shares Diluted restated Q1 2025 · Mar 31, 2024 408.94M sh
Capex Q1 2025 · Mar 31, 2024 $3.14M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$47.78M
Sga Expense Q1 2025 · Mar 31, 2024 $76.42M
Net Income Q1 2025 · Mar 31, 2024 −$6.06M
Operating Income Q1 2025 · Mar 31, 2024 −$7.18M
Revenue Q1 2025 · Mar 31, 2024 $1.6B